Raise Capital Like an Operator, Not a Founder in Search of Validation
Raise Capital Like an Operator, Not a Founder in Search of Validation Most founders walk into a raise wanting money. Serious operators walk into a raise wanting alignment. That sounds like semantics...
Why Recycled Warm Intros Stop Working in a High-Scrutiny Market
Why Recycled Warm Intros Stop Working in a High-Scrutiny Market A warm intro can still get you in the room. It just cannot do the underwriting for you. That distinction matters a lot more now than it...
Why Bad Follow-Up Kills More Raises Than Bad First Meetings.
Why Bad Follow-Up Kills More Raises Than Bad First Meetings. Most founders think they lose a raise in the first meeting. Sometimes they do. But not nearly as often as they think. In my experience,...
Attention Is the Real Capital Scarcity Problem for Emerging Managers
There is still a massive amount of money in private markets. The capital pools available to allocators have never felt larger. The real choke point for emerging managers is not capital — it is attention.
Why Warm Intros Are Overrated in Fundraising
Warm intros make founders and emerging managers feel like progress is happening. But access is not conviction. Here is what serious investors are actually evaluating once the meeting starts.
The Second-Meeting Test: What Serious LPs Look For After the Deck
First meetings are chemistry. Second meetings are competence. That is the stage too many emerging managers misunderstand. They think the first meeting is the hard
Your CRM Is Not Broken. Your Capital Raise Is.
According to Goldman Sachs's 2025 Family Office Investment Insights, family offices allocate an average of 21% of portfolios to private equity and 39% plan to increase that allocation — meaning the ca
If Your LP Pipeline Lives in Your Inbox, Your Raise Is Already at Risk
If Your LP Pipeline Lives in Your Inbox, Your Raise Is Already at Risk According to Gen II Fund Services' 2026 Emerging Manager Report , the number of LP meetings required per committed investor has
Your Data Room Is Quietly Telling LPs You're Not Ready
Your Data Room Is Quietly Telling LPs You're Not Ready According to PipelineRoad's Fundraising Data Room Guide , managers who launched with a complete data room consistently compressed their
Multifamily Syndications: Real Returns From Tracked Deals Since 2023
Multifamily Syndications: Real Returns From Tracked Deals Since 2023 TL;DR: The 2021-2022 multifamily syndication vintage is the worst retail real estate investor loss cycle since 2008 CMBS. GVA Real Estate admitted 80%...
Wefunder vs StartEngine vs Republic: The 2026 Platform Reality
Wefunder vs StartEngine vs Republic: The 2026 Platform Reality TL;DR: Per SEC DERA data through December 2024 , only 2.2% of Reg CF issuers have ever given investors an exit via acquisition, and just 0.25% have IPO'd....
Why I'm Watching Private Credit Interval Funds Right Now
Why I'm Watching Private Credit Interval Funds Right Now TL;DR: The average alternative credit interval fund (ACIF) yield dropped 110 basis points in 2025 — from 10.4% to 9.3% — while the category swelled to 91 funds...
AeQuitas Invest RegCF: Women-Only Crowdfunding Portal
AeQuitas Invest launched as a SEC-registered Reg CF funding portal exclusively for women-owned businesses, connecting female entrepreneurs with investors nationwide and expanding capital access through regulated crowdfunding.
Strategic Health Funds Replace Traditional VC in Medtech
Strategic health venture funds are replacing traditional generalist VCs in medtech financing. Ajax Health Fund's $60M solo investment in UroMems demonstrates how specialized health funds provide regulatory expertise and market knowledge generalist VCs cannot match.
CLARITY Act 2026: What Crypto Regulation Means for Institutional Investors
The CLARITY Act 2026 establishes the first comprehensive regulatory framework for digital assets, assigning SEC authority over token sales and CFTC control over secondary market trading. Learn what this means for institutional capital deployment.
Private Credit Fund India: ASK's ₹2,500 Crore Bet
ASK Alternates launched a ₹2,500 crore private credit fund targeting 14-16% gross IRR by lending to infrastructure, healthcare, and manufacturing companies rejected by traditional Indian banks.
In Healthcare Investing, Credibility Is Now Part of Due Diligence
Credibility is now a core due diligence factor in healthcare investing. Investors must underwrite not just science and execution, but whether institutions shaping the narrative can be trusted when pressure emerges.
Hantavirus Isn’t COVID 2.0 — But It Is a Stress Test for Everything We Claimed We Fixed
Hantavirus is rodent-borne with limited person-to-person transmission—not a COVID replay. The real question: did institutions, leaders, and households actually improve decision-making and crisis response after 2020, or repeat reactive patterns?
What COVID Taught Serious Investors About Healthcare Supply Chain Fragility
COVID revealed that healthcare supply chain fragility—not just science or demand—destroys execution and enterprise value. Serious investors now recognize supplier concentration, inventory, and logistics vulnerabilities as critical due-diligence factors.
How to Start a Corporate Venture Capital Fund: SEC Compliance
Learn SEC compliance requirements for launching a corporate venture capital fund, including registration thresholds, Exempt Reporting Adviser status, and unique regulatory challenges facing corporate VC structures versus traditional funds.